Melqart Asset Management (UK) Ltd

Position in RVMD — Revolution Medicines, Inc.

CIK 1712901 London, X0

Position in RVMD

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$22,718,562

-$3,574,239 QoQ

Shares Held

121,308

-55.1% QoQ

Ownership

0.057%

of shares outstanding

% of Portfolio

2.31%

of 13F equity value

Holder Rank

#124

of 685 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Melqart Asset Management (UK) Ltd holds $144,610,610 across 5 Biotechnology names. RVMD ranks #3 (15.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CYTK	Cytokinetics Inc	767,525	$65,385,454
2	ABVX	Abivax S.A.	307,250	$40,944,135
3	RVMD	Revolution Medicines, Inc. This page	121,308	$22,718,562
4	APGE	Apogee Therapeutics, Inc.	117,249	$15,562,459
5	CPRX	Catalyst Pharmaceuticals, Inc.	247,556	$0

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$22,718,562	121,308	-55.1%	Shares	Sole	2026-08-14
2026-03-31	$26,292,801	270,363	—	Shares	Sole	2026-05-12
No filing history on record for this holder in this stock.